In this study's GBM cohort, both IDHWT and IDHMUT GBM had VUS that were predicted to be pathogenic in MSH6 [45–47], CREBBP [48–52], TP53 [17, 47], and TSC2 [36–43, 53]. This evidence concerns the gene TSC2 and glioblastoma.